Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy

Clinical trial NCT01838850 · COMPLETED

Trial details

NCT number: NCT01838850
Sponsor: Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2013-04-01
Primary completion: 2014-08-01
Enrollment: 344

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.